152342-26-2Relevant articles and documents
Discovery of benzimidazole derivatives as modulators of mitochondrial function: A potential treatment for Alzheimer's disease
Kim, TaeHun,Yang, Ha Yun,Park, Beoung Gun,Jung, Seo Yun,Park, Jong-Hyun,Park, Ki Duk,Min, Sun-Joon,Tae, Jinsung,Yang, Hyejin,Cho, Suengmok,Cho, Sung Jin,Song, Hyundong,Mook-Jung, Inhee,Lee, Jiyoun,Pae, Ae Nim
, p. 1172 - 1192 (2016/11/23)
In this study, we designed a library of compounds based on the structures of well-known ligands of the 18 kDa translocator protein (TSPO), one of the putative components of the mPTP. We performed diverse mitochondrial functional assays to assess their ability to restore cells from Aβ-induced toxicity in vitro and in vivo. Among tested compounds, compound 25 effectively improved cognitive function in animal models of AD. Given the excellent in vitro and in vivo activity and a favorable pharmacokinetic profile of compound 25, we believe that it can serve as a promising lead compound for a potential treatment option for AD.
Research In The Imidazole Series. 93. Synthesis Of Derivatives Of Benzimidazolyl-1-Acetic Acid
Kochergin, P. M.,Palei, R. M.,Chernyak, S. A.
, p. 560 - 562 (2007/10/02)
A simple method has been developed for obtaining esters of benzimidazolyl-1-acetic acid and its 2-alkyl (or aralkyl) derivatives, by reaction of benzimidazoles with esters of chloroacetic or bromoacetic acid in DMF in the presence of anhydrous potassium c